Compare ORC & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ORC | PRGO |
|---|---|---|
| Founded | 2010 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 2011 | 2013 |
| Metric | ORC | PRGO |
|---|---|---|
| Price | $6.70 | $10.72 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 2 | 3 |
| Target Price | $7.50 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 4.1M | 2.5M |
| Earning Date | 04-23-2026 | 05-06-2026 |
| Dividend Yield | ★ 17.07% | 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | $21.28 | N/A |
| Revenue Next Year | $5.71 | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.57 | $9.23 |
| 52 Week High | $8.40 | $28.44 |
| Indicator | ORC | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 41.27 | 45.23 |
| Support Level | $6.65 | $10.46 |
| Resistance Level | $7.32 | $12.36 |
| Average True Range (ATR) | 0.12 | 0.45 |
| MACD | -0.01 | -0.05 |
| Stochastic Oscillator | 33.75 | 38.69 |
Orchid Island Capital Inc is a specialty finance company that invests in residential mortgage-backed securities. The principal and interest payments of its RMBS are guaranteed by the Federal National Mortgage Association, the Federal Home Loan Mortgage Corporation, or the Government National Mortgage Association, and are backed by single-family residential mortgage loans. The company's investment portfolio is divided into two categories namely traditional pass-through Agency RMBS; and structured Agency RMBS, such as collateralized mortgage obligations, interest-only securities, inverse interest-only securities, and principal-only securities, among other types of structured Agency RMBS.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.